FibroGen, Inc. (FGEN) Earnings History
Annual and quarterly earnings data from 2012 to 2024
Loading earnings history...
FGEN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
FGEN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 47.5% | -507.8% | -160.6% |
| 2023 | 91.5% | -689.5% | -607.3% |
| 2022 | 85.6% | -213.9% | -208.7% |
| 2021 | -90.9% | -122.6% | -123.3% |
| 2020 | 95.0% | -108.8% | -107.4% |
Download Data
Export FGEN earnings history in CSV or JSON format
Free sign-in required to download data
FibroGen, Inc. (FGEN) Earnings Overview
As of May 8, 2026, FibroGen, Inc. (FGEN) reported trailing twelve-month net income of $216M, reflecting +83.6% year-over-year growth. The company earned $53.33 per diluted share over the past four quarters, with a net profit margin of -160.6%.
Looking at the long-term picture, FGEN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$15M in fiscal 2013.
FibroGen, Inc. maintains positive profitability with a gross margin of 47.5%, operating margin of -507.8%, and net margin of -160.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AKBA (-$21M net income, -2.3% margin), PTCT (-$187M net income, 39.4% margin), FOLD (-$27M net income, -4.3% margin), FGEN has room to improve margins relative to the peer group. Compare FGEN vs AKBA →
FGEN Earnings vs Peers
Earnings metrics vs comparable public companies
FGEN Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$48M | +83.3% | -$150M | $-0.48 | -160.6% | -507.8% |
| 2023 | -$284M | +3.2% | -$323M | $-2.92 | -607.3% | -689.5% |
| 2022 | -$294M | -1.3% | -$301M | $-3.15 | -208.7% | -213.9% |
| 2021 | -$290M | -53.2% | -$289M | $-3.15 | -123.3% | -122.6% |
| 2020 | -$189M | -145.9% | -$192M | $-2.11 | -107.4% | -108.8% |
| 2019 | -$77M | +10.9% | -$89M | $-0.89 | -30.0% | -34.8% |
| 2018 | -$86M | +31.5% | -$87M | $-1.03 | -40.6% | -40.7% |
| 2017 | -$126M | -104.6% | -$123M | $-1.73 | -100.4% | -97.6% |
| 2016 | -$62M | +28.1% | -$54M | $-0.98 | -34.3% | -29.9% |
| 2015 | -$86M | -44.2% | -$78M | $-1.42 | -47.4% | -42.9% |
See FGEN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FGEN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FGEN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFGEN — Frequently Asked Questions
Quick answers to the most common questions about buying FGEN stock.
Is FGEN growing earnings?
FGEN EPS is $53.33, with earnings growth accelerating to +83.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $216M.
What are FGEN's profit margins?
FibroGen, Inc. net margin is -160.6%, with operating margin at -507.8%. Below-average margins reflect competitive or cost pressures.
How consistent are FGEN's earnings?
FGEN earnings data spans 2012-2024. The accelerating earnings trend is +83.6% YoY. Historical data enables comparison across business cycles.